CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Total net revenue	$ 97,862	$ 88,694	$ 284,186	$ 246,318
Operating expenses:
Research and development	449	1,010	536	1,569
General and administrative	2,860	3,254	13,074	8,413
Total operating expenses	3,309	4,264	13,610	9,982
Income from operations	94,553	84,430	270,576	236,336
Other income (expense), net	(652)	(13)	(2,036)	85
Interest income	453	41	503	1,501
Interest expense	(4,790)	(4,603)	(14,229)	(13,680)
Changes in fair values of equity and long-term investments, net	33,613	(29,368)	133,973	39,245
Income before income taxes	123,177	50,487	388,787	263,487
Income tax expense, net	20,531	8,866	65,600	44,689
Net income	102,646	41,621	323,187	218,798
Net income attributable to noncontrolling interest	30,208	13,403	67,678	48,299
Net income attributable to Innoviva stockholders	$ 72,438	$ 28,218	$ 255,509	$ 170,499
Basic net income per share attributable to Innoviva stockholders	$ 1.04	$ 0.28	$ 2.96	$ 1.68
Diluted net income per share attributable to Innoviva stockholders	$ 0.90	$ 0.26	$ 2.63	$ 1.53
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	69,458	101,358	86,298	101,306
Shares used to compute diluted net income per share	81,699	113,572	98,536	113,543
Royalty revenue from a related party
Total net revenue	$ 97,862	$ 88,694	$ 284,186	$ 236,318
Revenue from collaborative arrangements with a related party
Total net revenue	$ 0	$ 0	$ 0	$ 10,000